HKD 4.57
(5.79%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.22 Billion HKD | 35.37% |
2022 | 907.87 Million HKD | -7.63% |
2021 | 982.88 Million HKD | 71.33% |
2020 | 573.66 Million HKD | -18.55% |
2019 | 704.33 Million HKD | -1.27% |
2018 | 713.39 Million HKD | 29.97% |
2017 | 548.9 Million HKD | 19.97% |
2016 | 457.54 Million HKD | 15.17% |
2015 | 397.28 Million HKD | 27.37% |
2014 | 311.92 Million HKD | 32.13% |
2013 | 236.07 Million HKD | 21.83% |
2012 | 193.76 Million HKD | 26.29% |
2011 | 153.43 Million HKD | 48.76% |
2010 | 103.14 Million HKD | 21.46% |
2009 | 84.91 Million HKD | 19.94% |
2008 | 70.8 Million HKD | 25.32% |
2007 | 56.49 Million HKD | 23.2% |
2006 | 45.86 Million HKD | 22.99% |
2005 | 37.28 Million HKD | 38.65% |
2004 | 26.89 Million HKD | -31.82% |
2003 | 39.44 Million HKD | 35.93% |
2002 | 29.02 Million HKD | 35.78% |
2001 | 21.37 Million HKD | 25.84% |
2000 | 16.98 Million HKD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 568.06 Million HKD | 0.0% |
2023 Q2 | 621.94 Million HKD | 0.0% |
2023 FY | 1.22 Billion HKD | 35.37% |
2023 Q4 | 600.89 Million HKD | 0.0% |
2022 FY | 907.87 Million HKD | -7.63% |
2022 Q2 | 441.62 Million HKD | 0.0% |
2022 Q4 | 474.72 Million HKD | 0.0% |
2021 Q2 | 446.72 Million HKD | 0.0% |
2021 FY | 982.88 Million HKD | 71.33% |
2021 Q4 | 545.89 Million HKD | 0.0% |
2020 Q2 | 210.75 Million HKD | 0.0% |
2020 Q4 | 376.28 Million HKD | 0.0% |
2020 FY | 573.66 Million HKD | -18.55% |
2019 FY | 704.33 Million HKD | -1.27% |
2019 Q4 | 378.04 Million HKD | 0.0% |
2019 Q2 | 335.25 Million HKD | 0.0% |
2018 Q2 | 336.51 Million HKD | 0.0% |
2018 FY | 713.39 Million HKD | 29.97% |
2018 Q4 | 359.9 Million HKD | 0.0% |
2017 FY | 548.9 Million HKD | 19.97% |
2017 Q4 | 274.19 Million HKD | 0.0% |
2017 Q2 | 263.47 Million HKD | 0.0% |
2016 Q2 | 222.46 Million HKD | 0.0% |
2016 FY | 457.54 Million HKD | 15.17% |
2016 Q4 | 232.08 Million HKD | 0.0% |
2015 Q2 | 191.29 Million HKD | 0.0% |
2015 Q4 | 205.86 Million HKD | 0.0% |
2015 FY | 397.28 Million HKD | 27.37% |
2014 Q4 | 161.11 Million HKD | 0.0% |
2014 Q2 | 150.78 Million HKD | 0.0% |
2014 FY | 311.92 Million HKD | 32.13% |
2013 FY | 236.07 Million HKD | 21.83% |
2013 Q4 | 122.29 Million HKD | 0.0% |
2013 Q2 | 113.75 Million HKD | 0.0% |
2012 FY | 193.76 Million HKD | 26.29% |
2012 Q4 | - HKD | 0.0% |
2012 Q2 | - HKD | 0.0% |
2011 Q2 | - HKD | 0.0% |
2011 Q4 | - HKD | 0.0% |
2011 FY | 153.43 Million HKD | 48.76% |
2010 FY | 103.14 Million HKD | 21.46% |
2010 Q2 | 26.06 Million HKD | 0.0% |
2009 Q2 | 20.18 Million HKD | 0.0% |
2009 FY | 84.91 Million HKD | 19.94% |
2008 FY | 70.8 Million HKD | 25.32% |
2007 FY | 56.49 Million HKD | 23.2% |
2006 FY | 45.86 Million HKD | 22.99% |
2005 FY | 37.28 Million HKD | 38.65% |
2004 FY | 26.89 Million HKD | -31.82% |
2003 FY | 39.44 Million HKD | 35.93% |
2002 FY | 29.02 Million HKD | 35.78% |
2001 FY | 21.37 Million HKD | 25.84% |
2000 FY | 16.98 Million HKD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Pak Fah Yeow International Limited | 24.42 Million HKD | -4931.785% |
Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 68.167% |
Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -3359.237% |
Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -247.23% |
Qianhai Health Holdings Limited | 17.1 Million HKD | -7086.079% |
Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -107.949% |
Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -144.102% |
PuraPharm Corporation Limited | 216.62 Million HKD | -467.312% |
SSY Group Limited | 1.98 Billion HKD | 37.954% |
JBM (Healthcare) Limited | 163.87 Million HKD | -649.935% |
Jacobson Pharma Corporation Limited | 287.34 Million HKD | -327.69% |
China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 95.813% |